The global contingent heart disease market is anticipated to grow at a CAGR of nearly 9.1% during the forecast period (2024-2031). Key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launch, and product innovation to remain competitive in the marketplace. […]
